SAFEPASS: A polyurea-concrete construction system to improve safety in the conservation of infrastructures
November 29, 2023
More reliable and more durable ammonia sensors to improve the well-being of animals and reduce production costs on farms
January 18, 202404/12/2023
An international consortium of universities, hospitals and companies, led by the Centre for Sensors, Instruments and Systems Development (CD6) at the UPC, is developing new technologies based on light and artificial intelligence to improve the diagnosis of various diseases.
New photonic and artificial intelligence (AI) tools will be developed for the early diagnosis and precise treatment of ocular, cardiovascular and neurodegenerative diseases. This is the objective of the European BE-LIGHT project, coordinated by the Centre for Sensors, Instruments and Systems Development (CD6) at the Universitat Politècnica de Catalunya - BarcelonaTech (UPC). Participants in this project include a total of seven academic institutions, three hospitals and seven companies in Germany, France, Poland, Switzerland and Spain.
The BE-LIGHT project represents a step forward for knowledge and diagnosis of retinal diseases. Through the use of neural networks and optogenetic techniques, the new tools that are developed will promote better understanding of the functioning of the retina and the exchange of information between neurons, so that, based on quantitative models, retinal diseases can be detected.
The combination of various photonic technologies such as multispectral images and optical coherence tomography, complemented with AI algorithms, enables a precise analysis of various ocular structures (cornea, vitreous body, fundus) for the early detection of visual impairments and oculomotor disorders. In addition, assessment with AI of eye movement patterns, which are strongly controlled by several brain areas, could offer new diagnostic tools for neurological diseases, such as Alzheimer or long Covid.
The project will also make possible the development of new clinical instruments and methods that can be used, for example, to obtain images of blood vessels or ocular structures of the patient through optical tomography and optoacoustics or thermal image. This technology will help in the non-invasive, early detection of plaques of arteriosclerosis, among other disorders. Likewise, new automatic learning tools will be developed for the treatment and monitoring of cardiac arrythmias with light, which could replace current techniques based on electrical stimuli. The use of AI in combination with techniques of super-resolution microscopy will enable images of biological structures of less than a nanometre to be obtained, such as proteins involved in Parkinson’s disease and other rare diseases, which will improve the diagnosis.
Budget and funding
The consortium, led by Meritxell Vilaseca, researcher at CD6 and Cristina Masoller, researcher in the group Nonlinear Dynamics, Nonlinear Optics and Lasers (DONLL), has funding of 2.5 million euros from the European Union’s Horizon Europe programme, within the Marie Sklodowska Curie (Doctoral Networks) Actions. BE-LIGHT has a duration of 48 months (October 2023 – September 2027).
Researchers Cristina Masoller and Meritxell Vilaseca in the laboratory
The initial project meeting was held in Barcelona in November
International team involved in the project
Related Projects
- Microalgae-based wastewater treatment systems have demonstrated the ability to recover nutrients from wastewater and produce valuable biomass for agricultural applications while also recovering energy through the anaerobic digestion of residual biomass. In the Cyan2Bio project, in which the Group of Environmental Engineering and Microbiology (GEMMA) of the Universitat Politècnica de Catalunya - BarcelonaTech (UPC) is participating, an additional step will be taken in the valorisation of microalgae biomass to obtain biopolymers suitable for transformation into bioplastics alongside pigments, thereby replacing fossil-based materials.
- Neurodegenerative diseases, such as Parkinson's disease, Alzheimer's, and age-related disorders, have been widely studied due to their significant impact on individuals and society. So far, these are incurable and debilitating diseases that lead to progressive degeneration and death of nerve cells, resulting in cognitive and mobility impairments. Tremors, mainly at rest, slowness of movement (bradykinesia), limb rigidity, and issues with gait and balance are typical motor disorders related to Parkinson’s disease. Additionally, due to progressive muscle atrophy, these issues can lead to falls, which in turn result in further complications and risks to quality of life.
- The energy transition is reshaping the foundations of the power grid, driven by the massive deployment of renewable generation based on power electronics and the gradual disconnection of conventional fossil-based generation. In this context, grid operators will require support systems to provide flexibility, as renewable generation is highly variable.
- The Biological Treatment of Gaseous Pollutants and Odours Group (BIOGAP) at UPC is participating in the BIOMETCRI project, which aims to implement an innovative biotechnological process to recycle batteries from electric and hybrid vehicles, recovering valuable metals such as cobalt, lithium, nickel, and manganese.
